drugset / Trial / NCT01611909

Citriodiol® and Impetigo

NCT01611909 ↗

Phase 2/3 Unknown 30 enrolled Royal North Shore Hospital
RandomizedCrossoverTriple-blindTreatment

Summary

This study aims to investigate the efficacy and safety of topical p-menthane-3,8-diol (PMD)-rich Corymbia Citriodora oil (Citriodiol®) in children with impetigo. Citriodiol® is already known to be effective as an insect repellent and is safe in its topical application. The investigators have also found in our laboratory that it is bactericidal against Staphylococcus aureus, the bacteria responsible for causing impetigo. Parents are always searching for a natural alternative to antibiotics (the current gold standard treatment for impetigo), and the investigators believe Citriodiol® could provide this possible alternative.

Timeline

Start
2012-07
Primary completion
2013-01
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject p-menthane-3,8-diol Unknown 2 % Topical
Subject p-menthane-3,8-diol Unknown 5 % Topical

Indications